BIOINVENU CORPORATION
East Hanover, NJ · Biotech · Private
MORLinkLight assay for screening molecules that modulate mu-opioid receptor trafficking and signaling
- Grants
- $2.5M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20152017201920212023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Novel tools for investigating GPCR-mediated 14-3-3 signaling pathway | $330,536 | |
| Federal grant | Department of Health and Human Services · Phase II · Novel tools for investigating GPCR-mediated 14-3-3 signaling pathway | $773,235 | |
| Federal grant | Department of Health and Human Services · Phase II · Novel tools for investigating GPCR-mediated 14-3-3 signaling pathway | $766,778 | |
| Federal grant | Department of Health and Human Services · Phase I · Screen molecules modulating MOR trafficking with a newly developed MOR/14-3-3 bioassay. | $321,000 | |
| Federal grant | Department of Health and Human Services · Phase I · New 5HT2AR Target Identification and Assay Development for Discovering Psychoplastogenic Compounds | $319,343 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2373 | Eluciderm Inc. | — | $3.8M |
| 2374 | BIO-PATH HOLDINGS, INC. | — | $18M |
| 2375 | Indapta Therapeutic | — | — |
| 2376 | BIOINVENU CORPORATION | — | — |
| 2377 | DNP THERAPEUTICS INC | — | $470K |
| 2378 | XFIBRA, INC. | — | — |
| 2379 | ISIS PHARMACEUTICALS INC | — | $201M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.